Reuben Henderson, DO
Physical Medicine & Rehabilitation · Lansing, MINPI 1851463228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- Collegium Pharmaceutical, Inc.$776
- Pfizer$209
- Orexo US, Inc.$204
- Teva Pharmaceuticals USA, Inc.$165
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$161
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,529100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $789 |
| Collegium Pharmaceutical, Inc. | 44 | $776 |
| Pfizer | 12 | $209 |
| Orexo US, Inc. | 12 | $204 |
| Teva Pharmaceuticals USA, Inc. | 10 | $165 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $161 |
| Amgen | 9 | $159 |
| Sentynl Therapeutics, Inc. | 17 | $138 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $103 |
| Medtronic | 5 | $90 |
| Supernus Pharmaceuticals, Inc. | 5 | $86 |
| Redhill Biopharma Inc. | 4 | $72 |
| Braeburn Inc. | 3 | $60 |
| Indivior Inc. | 3 | $59 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Avanir Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $49 |
| Averitas Pharma Inc. | 2 | $36 |
| GRT US Holding, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $31 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Hikma Pharmaceuticals USA | 1 | $26 |
| Novartis | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,529 in reported general payments places this provider in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BetaseronInterferon Beta-1b | 13 | $122,091 |
| OxycontinOxycodone Hcl | 101 | $92,953 |
| Xtampza ErOxycodone Myristate | 44 | $39,255 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 198 | $36,275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,273 | $31,871 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 857 | $29,069 |
| Nurtec OdtRimegepant Sulfate | 18 | $26,017 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 22 | $24,683 |
| Oxycodone Hcl | 628 | $19,313 |
| QuliptaAtogepant | 19 | $18,250 |
| Morphine Sulfate ErMorphine Sulfate | 346 | $13,994 |
| MovantikNaloxegol Oxalate | 37 | $13,848 |
| Hydromorphone Hcl | 373 | $12,218 |
| Oxymorphone Hcl ErOxymorphone Hcl | 15 | $11,876 |
| Fentanyl | 106 | $11,573 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate | $26 | $45,822483 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $776 | $39,25544 claims |
| PfizerNurtec Odt | $209 | $26,01718 claims |
| Orexo US, Inc.Zubsolv | $204 | $24,68322 claims |
| AbbVieQulipta, Linzess | $789 | $23,86930 claims |
| Redhill Biopharma Inc.Movantik | $72 | $13,84837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
Other physical medicine & rehabilitation in Lansing
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
- In YoonDearborn$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.